Bear, Stearns International Limited Hires Rachna Upadhya to Join Their European Equity Research Pharmaceutical Team

Roger Hirst, Head of European Equity Research, said, "Rachna is anexcellent analyst with a strong medical and business background.Rachna and Marietta Miemietz, who joined us recently from HSBC,significantly strengthen our European Healthcare research, and we arenow able to extend our coverage and reach out to more clients."

Prior to joining BSIL Ms. Upadhya was covering large cappharmaceuticals at UBS and before that she covered EuropeanPharmaceutical stocks for Merrill Lynch. Ms. Upadhya holds medicaldegrees and an MBA from Imperial Management School in London.

BSIL is a wholly owned subsidiary of The Bear Stearns CompaniesInc. (NYSE: BSC) BSIL currently employs approximately 1,000 staff inLondon who serve corporations, institutions, partnerships andgovernmental entities in the United Kingdom, Europe and the MiddleEast. BSIL's capabilities include investment banking, institutionalequities and fixed income sales, trading and research, derivativeproducts, financial futures, foreign exchange, private client servicesand global clearing.